GABA and Inhibitory Neurotransmission

Gamma-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter of the mammalian central nervous system. By opening chloride-permeable channels and activating modulatory receptors, GABA dampens neuronal excitability and balances the excitation provided by glutamate. The GABA-A receptor is the molecular target of several major sedative-hypnotic and anticonvulsant drug classes, making this system central to neuropsychopharmacology.

Definition

GABAergic neurotransmission is inhibitory signalling by gamma-aminobutyric acid, which is synthesised from glutamate by glutamic acid decarboxylase and acts through ionotropic GABA-A receptors (ligand-gated chloride channels) and metabotropic GABA-B receptors to reduce the excitability of target neurons.

Scope

The topic covers the synthesis of GABA, its fast (ionotropic GABA-A) and slow (metabotropic GABA-B) receptor systems, and how the GABA-A receptor's subunit architecture creates distinct sites at which drugs act as positive allosteric modulators. It treats inhibitory neurotransmission as reference knowledge underlying CNS pharmacology, without giving prescribing or dosing guidance.

Core questions

• How is GABA synthesised and how does it inhibit neurons?
• How do ionotropic GABA-A and metabotropic GABA-B receptors differ?
• How does GABA-A receptor subunit composition determine pharmacology?
• Why is the GABA-A receptor an important drug target?

Key concepts

• Gamma-aminobutyric acid (GABA)
• Glutamic acid decarboxylase
• Ionotropic GABA-A receptor (chloride channel)
• Metabotropic GABA-B receptor
• Positive allosteric modulation
• GABA-A receptor subunit composition

Key theories

Excitation-inhibition balance

The framework that normal brain function depends on a tuned balance between glutamatergic excitation and GABAergic inhibition, with disturbances of this balance implicated in seizures and in other disorders of neural excitability.

Mechanisms

GABA is synthesised from glutamate by glutamic acid decarboxylase and, once released, acts on two receptor classes. The ionotropic GABA-A receptor is a pentameric ligand-gated chloride channel whose opening hyperpolarises or shunts the target neuron, producing fast inhibition; its subunit composition determines its pharmacology and creates distinct allosteric sites, as detailed by Olsen and Sieghart (2008) and Sigel and Steinmann (2012). The metabotropic GABA-B receptor is G-protein-coupled and produces slower inhibition through potassium and calcium channel modulation. Several drug classes act as positive allosteric modulators of GABA-A receptors, enhancing the channel's response to GABA rather than opening it directly. Inhibitory signalling is terminated by GABA transporters that clear the transmitter from the synapse.

Clinical relevance

Because GABA-A receptors mediate much of fast inhibition, agents that enhance their function are associated with sedative, anxiolytic, and anticonvulsant effects, and loss of inhibitory balance is relevant to seizure disorders. This entry describes those mechanisms as background to CNS pharmacology and is not a basis for selecting or dosing any medication.

Evidence & guidelines

GABA-A receptor classification follows the IUPHAR consensus nomenclature; the cited Olsen and Sieghart (2008) update and the Sigel and Steinmann (2012) review provide the authoritative descriptions used here.

History

GABA was recognised as a central inhibitory transmitter in the mid-twentieth century, overturning the earlier assumption that amino acids were merely metabolic. Subsequent molecular cloning revealed the multi-subunit GABA-A receptor and its allosteric sites, explaining how structurally diverse drugs converge on inhibitory neurotransmission and establishing the receptor as a key pharmacological target.

Seminal works

• olsen-sieghart-2008
• sigel-steinmann-2012

Frequently asked questions

Why is GABA called the main inhibitory neurotransmitter?

Because GABA acts at receptors that reduce neuronal excitability, chiefly by opening chloride channels through the GABA-A receptor, counterbalancing the excitation produced by glutamate throughout the central nervous system.

What is the difference between GABA-A and GABA-B receptors?

GABA-A receptors are fast ligand-gated chloride channels (ionotropic), whereas GABA-B receptors are G-protein-coupled (metabotropic) and produce slower, modulatory inhibition.